At a glance
ClinicalIndex Comparison RecordN/ACompleted· 23 enrolled
Drug / intervention
questionnaire administration +2 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of High Dose Rate Brachytherapy as Definitive Management for Intermediate Risk Prostate Cancer
In Brief
A clinical study evaluating questionnaire administration, quality-of-life assessment, and 1 other intervention for Prostate Cancer. Completed, enrolled 23 participants across 1 site.
Detailed Summary
RATIONALE: Internal radiation therapy uses radioactive material placed directly into or near a tumor to kill tumor cells. PURPOSE: This clinical trial is studying the side effects and how well internal radiation therapy works in treating patients with prostate cancer.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsProstate Cancer
CountriesUnited States
CollaboratorsNational Cancer Institute (NCI)
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartNov 2007
First PostedDec 2007
Primary CompletionSep 2014
TodayJul 2026
First PostedDec 14, 2007
Enrollment StartNov 1, 2007
Primary CompletionSep 1, 2014
TodayJul 2, 2026
Enrollment to primary: 6.8 yearsPosted 18.6 years ago
Interventions
questionnaire administrationother
quality-of-life assessmentprocedure
brachytherapyradiation